If there is such a thing as a poster child for volatility in the stock market, the biotech sector would likely take top honors.Biotech stocks are unique. While stocks in other sectors are typically valued based on their past performance and future earnings potential, the majority of biotech stocks don’t have a cent in recurring revenue. Instead, biotech stocks are […]
They say good things come in threes. If so, biotech companies could be in for not just another year of outperformance, but another decade. The first era of biotech was a building phase, when companies created their first blockbuster drugs. The second, current one, has resulted in a four-year rally that reflects the sector’s transition from a cluster of one-hit […]
People have called me a “perma-bull” forever. Mish Shedlock called me a “wacko”. Zerohedge has called me insane. Nouriel Roubini has laughed in my face. My daughters still quote Don Luskin when he was on CNBC shaking his head and saying, “James, James, James…” while laughing after I said the market was going to hit new highs.
Well, the market has […]
These Promising Cancer Therapies Are a Biotech Stocks “Triple Play”Companies / BioTechJun 19, 2015 – 03:04 PM GMTBy: Money_MorningErnie Tremblay writes: On Jan. 7, 2015, CytRX Corp. (NASDAQ: CYTR) announced positive results from a study of its experimental brain cancer drug, aldoxorubicin, and the company’s stock immediately jumped 15.8%. Then, over the next four months, it nearly doubled.Over the months […]
An FDA advisory panel voted in favor of approving Regeneron (REGN – Analyst Report) and partner Sanofi’s PCSK9 inhibitor, Praluent. A few deals were also signed over the last few days by companies like Vertex (VRTX – Analyst Report), Celgene (CELG – Analyst Report) and Seattle Genetics (SGEN – Analyst Report).Recap of the Week’s Most Important Stories1. Regeneron and Sanofi […]
Biotech Indices Can’t Break Through Triple Top
IBB at $365, XBI at $239
Red and green day
Biotech stocks were mixed today with the major indices holding the flat line. However with all of the clinical data coming out of ASCO (American Society for Clinical Oncology) 2015 in Chicago, IL many “immuno-oncology” stocks were movers.
First look at Rayno Biopharmaceutical Portfolio stocks:
Our big mover […]
Biotechnology companies have been going public in record numbers, and many of them have been immediately embraced by public-market investors once their stock starts trading.But does that mean the sector is in a bubble?The chief executives of two venture-backed companies that went public spoke at the National Venture Capital Association’s annual conference in San Francisco. They said the good days for […]
In a recent report, analysts at JMP Securities discussed five biotech names that are on their radar. Here’s a breakdown of what they had to say.
BIND Therapeutics Inc (NASDAQ: BIND)
BIND will be presenting three posters on its Accurin technology at the American Association of Cancer Research (AACR) meeting in Philadelphia in April.Although the Accurin data the company will be showcasing […]
This article is written by Christian Tharp, the author of 5 Star Trading.The S&P 500 hit its last all-time high back at the end of 2014, and has chopped lower since.The Nasdaq has fared a bit better over that stretch, but the index still has yet to hit a new bull market high since the end of December.Through this period […]
Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case they’re material to our investing thesis.What: Shares of Array BioPharma (NASDAQ: ARRY ) , a biopharmaceutical company focused on the development of small molecule drugs for the treatment of cancer and inflammatory diseases, […]